The use of low-dose intravenous insulin in clinical myocardial F-18 FDG PET scanning.

The effectiveness of low-dose intravenous insulin boluses to improve study quality in F-18 FDG myocardial scans is investigated. Seventeen patients were imaged using a protocol in which only diabetic patients with fasting blood glucose levels > 8 mmol/l were given insulin. Fifty-three patients were imaged using a protocol in which all patients were given 1-3 IU intravenously of insulin immediately before F-18 FDG injection, based on fasting blood glucose levels. Scan quality was rated as poor, good, or excellent. Using the conventional protocol, 29% of the scans were poor quality (uniterpretable), 47% were good, and 23% were excellent. Using the low-dose intravenous insulin boluses protocol; 2% were poor, 53% were good, and 45% were excellent (P = 0.01). There were no significant differences in the proportion of diabetic patients, age, or fasting blood glucose levels. Low-dose intravenous insulin bolus is an easy and safe method of improving myocardial F-18 FDG scan quality in nondiabetic and diabetic patients.

[1]  H. Schelbert.  Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  U. Ruotsalainen,et al.  Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  R. Coleman,et al.  The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  G. Hutchins,et al.  Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. , 1991, Journal of the American College of Cardiology.

[5]  R. Hicks,et al.  Positron emission tomography myocardial viability studies in patients with diabetes mellitus viability , 1991 .

[6]  M. Schwaiger,et al.  Insulin-glucose clamp for standardization of metabolic conditions during F-18 fluoro-deoxyglucose pet imaging , 1991 .

[7]  M. Phelps,et al.  Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. , 1986, Circulation.

[8]  M E Phelps,et al.  Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia , 1983, Circulation.